vimarsana.com

Latest Breaking News On - Amphastar pharmaceuticals stock performance - Page 3 : vimarsana.com

Amphastar Pharmaceuticals (NASDAQ:AMPH) Lifted to Buy at StockNews com

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a report published on Thursday. A number of other equities analysts have also recently commented on the company. Piper Sandler raised their target price on Amphastar Pharmaceuticals from $66.00 to $71.00 in a report on Wednesday, […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.